Navigating the landscape of end-of-life care and access to medications like this drug in New South Wales, the state, requires a careful understanding of the detailed legal structure. Currently, Pentobarbital does not have a approved place on the Pharmaceutical Benefits Scheme (PBS) and is therefore not regularly prescribed by healthcare professiona